Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
October 20-21, 2015 - Parc 55, San Francisco, CA - USA
September 30, October 1, 2015 - ConventionPoint, SIX Swiss Exchange, Zürich - Switzerland
September 29, 2015 - Sofitel, New York, USA